Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy

Metastatic clear-cell renal cell carcinoma (ccRCC) affects thousands of patients worldwide each year. Antiangiogenic therapy has been shown to have beneficial effects initially, but resistance is eventually developed. Therefore, it is important to accurately track the response of cancer to different...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Juan D., Lin, Fanglue, Chiang, Yun-Chen, Chytil, Anna, Chong, Diana C., Bautch, Victoria L., Rathmell, W. Kimryn, Dayton, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743465/
https://www.ncbi.nlm.nih.gov/pubmed/29290798
http://dx.doi.org/10.7150/thno.19658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743465/
https://www.ncbi.nlm.nih.gov/pubmed/29290798
http://dx.doi.org/10.7150/thno.19658

Ejemplares similares